TherapeuticsMD (NASDAQ:TXMD) stock is rocketing higher on Tuesday following news of an acquisition deal with private equity firm EW Healthcare Partners.
The deal has EW Healthcare Partners planning a tender offer that will see it buying all outstanding shares of TXMD stock for $10 each in cash. This represents a 367.3% premium to the stock’s closing price on Friday.
The post Why Is TherapeuticsMD (TXMD) Stock Up 360% Today? originally appeared at InvestorPlace.